273 related articles for article (PubMed ID: 29908433)
1. A retrospective analysis of the association between providing nicotine replacement therapy at admission and motivation to quit and nicotine withdrawal symptoms during an inpatient psychiatric hospitalization.
Okoli CTC; Al-Mrayat YD; Shelton CI; Khara M
Addict Behav; 2018 Oct; 85():131-138. PubMed ID: 29908433
[TBL] [Abstract][Full Text] [Related]
2. Correlates of nicotine withdrawal severity in smokers during a smoke-free psychiatric hospitalization.
Soyster P; Anzai NE; Fromont SC; Prochaska JJ
Prev Med; 2016 Nov; 92():176-182. PubMed ID: 26892910
[TBL] [Abstract][Full Text] [Related]
3. Flexible and extended dosing of nicotine replacement therapy or varenicline in comparison to fixed dose nicotine replacement therapy for smoking cessation: rationale, methods and participant characteristics of the FLEX trial.
Tulloch H; Pipe A; Els C; Aitken D; Clyde M; Corran B; Reid RD
Contemp Clin Trials; 2014 Jul; 38(2):304-13. PubMed ID: 24861558
[TBL] [Abstract][Full Text] [Related]
4. Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness.
Stapleton JA; Watson L; Spirling LI; Smith R; Milbrandt A; Ratcliffe M; Sutherland G
Addiction; 2008 Jan; 103(1):146-54. PubMed ID: 18028247
[TBL] [Abstract][Full Text] [Related]
5. Anxiety Sensitivity and Distress Tolerance in Smokers: Relations With Tobacco Dependence, Withdrawal, and Quitting Success†.
Schlam TR; Baker TB; Smith SS; Cook JW; Piper ME
Nicotine Tob Res; 2020 Jan; 22(1):58-65. PubMed ID: 31056710
[TBL] [Abstract][Full Text] [Related]
6. Negative affect subtypes and craving differentially predict long-term cessation success among smokers achieving initial abstinence.
Zuo Y; Rabinovich NE; Gilbert DG
Psychopharmacology (Berl); 2017 Mar; 234(5):761-771. PubMed ID: 28028602
[TBL] [Abstract][Full Text] [Related]
7. Smokers deprived of cigarettes for 72 h: effect of nicotine patches on craving and withdrawal.
Teneggi V; Tiffany ST; Squassante L; Milleri S; Ziviani L; Bye A
Psychopharmacology (Berl); 2002 Nov; 164(2):177-87. PubMed ID: 12404080
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of selectors of nicotine replacement therapy.
Shiffman S; Di Marino ME; Sweeney CT
Tob Control; 2005 Oct; 14(5):346-55. PubMed ID: 16183986
[TBL] [Abstract][Full Text] [Related]
9. Quitting experiences and preferences for a future quit attempt: a study among inpatient smokers.
Thomas D; Abramson MJ; Bonevski B; Taylor S; Poole SG; Weeks GR; Dooley MJ; George J
BMJ Open; 2015 Apr; 5(4):e006959. PubMed ID: 25888475
[TBL] [Abstract][Full Text] [Related]
10. Clinical management of tobacco dependence in inpatient psychiatry: provider practices and patient utilization.
Leyro TM; Hall SM; Hickman N; Kim R; Hall SE; Prochaska JJ
Psychiatr Serv; 2013 Nov; 64(11):1161-5. PubMed ID: 24185538
[TBL] [Abstract][Full Text] [Related]
11. Impact of messages on concomitant use of nicotine replacement therapy and cigarettes: a randomized trial on the Internet.
Etter JF; le Houezec J; Landfeldt B
Addiction; 2003 Jul; 98(7):941-50. PubMed ID: 12814500
[TBL] [Abstract][Full Text] [Related]
12. Reduction of abstinence-induced withdrawal and craving using high-dose nicotine replacement therapy.
Shiffman S; Ferguson SG; Gwaltney CJ; Balabanis MH; Shadel WG
Psychopharmacology (Berl); 2006 Mar; 184(3-4):637-44. PubMed ID: 16261317
[TBL] [Abstract][Full Text] [Related]
13. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
Shiffman S
Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
[TBL] [Abstract][Full Text] [Related]
14. Motivating smokers at outdoor public smoking hotspots to have a quit attempt with a nicotine replacement therapy sample: study protocol for a randomized controlled trial.
Cheung YT; Leung JP; Cheung CK; Li WH; Wang MP; Lam TH
Trials; 2016 Jul; 17(1):355. PubMed ID: 27456342
[TBL] [Abstract][Full Text] [Related]
15. Flexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trial.
Tulloch HE; Pipe AL; Els C; Clyde MJ; Reid RD
BMC Med; 2016 Jun; 14():80. PubMed ID: 27233840
[TBL] [Abstract][Full Text] [Related]
16. Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials.
Lerman C; Jepson C; Wileyto EP; Epstein LH; Rukstalis M; Patterson F; Kaufmann V; Restine S; Hawk L; Niaura R; Berrettini W
Neuropsychopharmacology; 2006 Jan; 31(1):231-42. PubMed ID: 16123753
[TBL] [Abstract][Full Text] [Related]
17. [Smoking reduction and temporary abstinence: new approaches for smoking cessation].
Le Houezec J; Säwe U
J Mal Vasc; 2003 Dec; 28(5):293-300. PubMed ID: 14978435
[TBL] [Abstract][Full Text] [Related]
18. Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks: A Randomized Clinical Trial.
Baker TB; Piper ME; Stein JH; Smith SS; Bolt DM; Fraser DL; Fiore MC
JAMA; 2016 Jan; 315(4):371-9. PubMed ID: 26813210
[TBL] [Abstract][Full Text] [Related]
19. The effect of nicotine dependence and withdrawal symptoms on use of nicotine replacement therapy: Secondary analysis of a randomized controlled trial in primary care.
Hollands GJ; Sutton S; Aveyard P
J Subst Abuse Treat; 2022 Jan; 132():108591. PubMed ID: 34391588
[TBL] [Abstract][Full Text] [Related]
20. The use of nicotine-replacement therapy by hospitalized smokers.
Rigotti NA; Arnsten JH; McKool KM; Wood-Reid KM; Singer DE; Pasternak RC
Am J Prev Med; 1999 Nov; 17(4):255-9. PubMed ID: 10606193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
